Chromium Polynicotinate (ChromeMate) found to Lengthen Life Span in Animal Study.

ChromeMate, a patented oxygen-coordinated, niacin-bound chromium, demonstrated its ability to prolong the life span of test animals by more than 20% in a study conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NB). Results of the study were presented at the 46th Annual Meeting of the American College of Nutrition, September 22-25, 2005, in Kiawah Island, South Carolina.

In the study, rats bred to be prone to many of the manifestations of aging were fed either a diet with or without ChromeMate. The test group had an average life span that was increased by 22% compared to rats fed a control diet. Rats fed ChromeMate also experienced lower systolic blood pressure, lower circulating glucose levels, and a trend toward lower, normalized hemoglobin levels, a long-term indicator of blood sugar status. There were no abnormalities in blood chemistry, kidney or liver function in either group.

The first death in the ChromeMate group did not occur until week 59, while the first death in the control group occurred at week 47. Thirty three percent of the animals in the ChromeMate group lived at least one month beyond the last animal in the control group.

"We've long known that niacin-bound chromium provides significant health benefits relative to metabolic syndrome," stated lead researcher, Harry G. Preuss, M.D. from Georgetown University Medical Center. "These new results open the possibility that ChromeMate niacin-bound chromium may prolong human life as well."